Eli Lilly, Novo Nordisk to lower Obesity Drug cost, strike pricing deal with Trump — 'Triumph for American patients'
Obesity drug prices are set to fall as Eli Lilly, Novo Nordisk secured deals with Trump administration.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
